Pradalex is a drug owned by ELANCO US INC. It is protected by 4 US drug patents filed from 2027 to 2039. All patents are active. Details of Pradalex’s patents and their expiration are given below.
Exclusivity Information
Pradalex holds 1 exclusivity out of which 0 have expired. Its last outstanding exclusivity is set to expire in 2027. Details of Pradalex's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | Apr 09, 2027 |
About Pradalex
Pradalex is a drug
owned by ELANCO US INC.
Pradalex uses
Pradofloxacin as the active
ingredient.
Active Ingredient:
Pradalex uses
Pradofloxacin as the active ingredient.
Check out other Drugs and Companies using
Pradofloxacin ingredient.